Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma.

R24 is an IgG3 mouse monoclonal antibody that identifies GD3, a prominent ganglioside on the surface of melanoma cells and other cells of neuroectodermal origin. Twelve patients with metastatic melanoma were treated with R24 at three dose levels, 8, 80, or 240 mg/m2, over a period of 2 weeks. Peak a...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Houghton, A N, Mintzer, D, Cordon-Cardo, C, Welt, S, Fliegel, B, Vadhan, S, Carswell, E, Melamed, M R, Oettgen, H F, Old, L J
Médium: Artigo
Jazyk:Inglês
Vydáno: 1985
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC397231/
https://ncbi.nlm.nih.gov/pubmed/3883355
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky